Skip to main content

Table 1 Patients’ characteristics and clinical data (Groups with significant differences are marked by an asterisk; one-way ANOVA)

From: Increased adipose tissue expression of TLR8 in obese individuals with or without type-2 diabetes: significance in metabolic inflammation

Parameter Non-diabetic Diabetic
Lean Overweight Obese Lean Overweight Obese
Total number (N) 9 17 23 3 10 32
Male (N) 3 11 13 2 6 18
Female (N) 6 6 10 1 4 14
Age (Yrs.) 25–53 29–71 26–66 48–58 45–59 23–72
Body mass index (kg/m2) 22.47 ± 2.52* 28.36 ± 1.10* 35.00 ± 3.45* 25.47 ± 0.34 27.87 ± 1.70 33.69 ± 2.55
Body fat percentage 27.73 ± 6.09 33.04 ± 4.95 39.09 ± 4.29 32.10 ± 6.22 31.29 ± 6.08 37.33 ± 5.04
Glucose (mmol/L) 4.94 ± 0.72 5.69 ± 1.63 5.24 ± 0.71 5.80 ± 0.42 9.04 ± 2.22 8.71 ± 2.91
Cholesterol (mmol/L) 5.53 ± 1.04 4.87 ± 0.81 5.05 ± 1.14 5.40 ± 2.55 4.91 ± 1.62 5.03 ± 1.23
High-density lipoprotein (mmol/L) 1.70 ± 0.48 1.20 ± 0.19 1.13 ± 0.24 1.14 ± 0.15 1.12 ± 0.40 1.15 ± 0.30
Low-density lipoprotein (mmol/L) 3.53 ± 0.92 3.14 ± 0.74 3.29 ± 1.01 3.70 ± 2.12 2.89 ± 1.37 2.98 ± 1.10
Triglycerides (mmol/L) 0.64 ± 0.25 1.18 ± 0.67 1.44 ± 0.89 1.25 ± 1.25 1.97 ± 0.83 1.89 ± 1.48
HbA1c (%) 5.74 ± 0.49 5.92 ± 1.70 5.68 ± 0.64 6.00 ± 0.28 7.91 ± 1.96 8.27 ± 1.50
Hypertension (N) 0 2 4 0 3 15
Hyperlipidemia (N) 0 0 1 0 2 4
Coronary artery disease (N) 0 0 1 0 1 1
Allergy (N) 0 0 1 0 0 2
Asthma (N) 1 1 0 0 0 3
Therapy Ventolin Nadolol, Zocor, Lipitor, Aspirin Concor, Lipitor, Aspirin, Diovan, Zyloric Metfornin, Aspirin Glucophage, Lipitor, Lantus, Zocor, Diovan, NovoRapid, Metformin, Aspirin NovoRapid, Lantus, Insulin, Aspirin, Concor, Zocor, Mixtard, Tenormin, Glucophage, Metformin, Capoten